International Journal of Pharmaceutical Sciences and Developmental Research Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    Prof. Pierre Guertin

    Prof. Pierre Guertin
    Laval University, Canada
    Email: pierre.guertin@crchudequebec.ulaval.ca
    Tel: +1 418-525-4444, pos
    Fax: +1 418-654-2753

    More Info.

    Editorial Board

    BEATA SARECKA-HUJAR
    phd
    Department of Pharmaceutical Technology
    Medical University of Silesia in Katowice
    Poland
    beatasarecka@poczta.onet.pl
    IJPSDR

    After graduation I started to work at Medical University of Silesia, where I completed my PhD thesis on genetic polymorphisms in coronary artery disease. Selected risk factors for development of arterial ischemic stroke in children were also in the area of my scientific interests. Besides, I am also interested in diagnosis and treatment of other neurological disorders in children: schizencephaly, headache, epilepsy and cerebral palsy. Nine years ago, when I moved to the Department of Pharmaceutical Technology I started the research concerning the technology for the manufacturing and optimization of micro- and nanocarriers of active substances. In addition, I am involved in analyses of rheological parameters of semi-solid preparations.


    Research Interest: developmental neurology, neuroscience, genetics, pharmaceutical technology, nanotechnology, biochemistry

    Grants: I participated in a multi-center Polish scientific grant and in several academic grants. In 2017, I was a supervisor of a grant of Medical University of Silesia regarding the release of active substances from semi-solid bases.


    List of Publications:
    Selected articles of my authorship:
    1. Beata Sarecka-Hujar, Ilona Kopyta. Poststroke epilepsy: current perspectives on diagnosis and treatment. Neuropsychiatr.Dis.Treat. 2019; Vol.15, p.95-103

    2. Joanna Sordyl, Ilona Kopyta, Beata Sarecka-Hujar, Tomasz Francuz, Paweł Matusik, Ewa Małecka-Tendera. Lipid levels and selected biomarkers of vascular changes in children with idiopathic headaches - a preliminary report. Arch.Med.Sci. 2019; Vol.15, No.1, p.120-125

    3. Beata Sarecka-Hujar, Andrzej Jankowski, Aneta Ostróżka-Cieślik, Radosław Balwierz, Anna Banyś, Renata Dyja, Dariusz Łukowiec, Dominik Marciniak, Janusz Pluta. Assessment of release of trimetazidine hydrochloride from orally disintegrating tablets (ODTs) prepared using different disintegrants. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.697-704

    4. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Tomasz Krzykawski, Jagna Karcz, Anna Banyś, Andrzej Jankowski. Application of selected diffractive and microscopic methods to evaluate the physical state of drug and morphology of microspheres obtained by spray drying of furosemide with Eudragit L30 D-55. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.759-765

    5. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek. Is the 1298A>C polymorphism in the MTHFR gene a risk factor for arterial ischaemic stroke in children? The results of meta.analysis. Clin.Exp.Med. 2018; Vol.18, No.3, p.337-345. 

    6. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Andrzej Jankowski. Physicochemical characteristics of furosemide incorporated Eudragit microspheres formulated by spray drying. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.6, p.1369-1376

    7. Beata Sarecka-Hujar, Radosław Balwierz, Aneta Ostróżka-Cieślik, Renata Dyja, Dariusz Łukowiec, Andrzej Jankowski. Scanning electron microscopy and X-ray energy dispersive spectroscopy - useful tools in the analysis of pharmaceutical products. J.Phys.: Conf.Series 2017; Vol.931, 012008, p.1-5

    8. Andrzej Jankowski, Renata Dyja, Beata Sarecka-Hujar. Dermal and transdermal delivery of active substances from semisolid bases. Indian J.Pharmaceut.Sci. 2017; Vol.79, No.4, p.488-500

    9. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. The use of nanotechnology in modern pharmacotherapy. In: Multifunctional systems for combined delivery, biosensing and diagnostics. / Editors: Alexandru Mihai Grumezescu, Amsterdam: Elsevier Inc., 2017, p. 139-158, ISBN: 978-0-323-52725-5

    10. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. Perspectives of the carbon nanoparticles use in cancer therapy and imaging. Post.Biol.Kom. 2017; T.44, nr 2, s.171-184

    11. Dorota Raczkiewicz, Beata Sarecka-Hujar, Alfred Owoc, Iwona Bojar. Cognitive functions and serum cortisol concentration in perimenopausal and postmenopausal women working non-manually. Neuroendocrinol.Lett. 2017; Vol.38, No.4, p.269-274

    12. Dorota Raczkiewicz, Alfred Owoc, Beata Sarecka-Hujar, Iwona Bojar. Pain involving the motor system and serum vitamin D concentration in postmenopausal women working in agriculture. Ann.Agric.Environ.Med. 2017; Vol.24, No.1, p.151-155

    13. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek, J. Sordyl. Association between the 20210G>A prothrombin gene polymorphism and arterial ischemic stroke in children and young adults - two meta-analyses of 3586 cases and 6440 control subjects in total. Pediatr.Neurol. 2017; Vol.69, p.93-101

    14. Beata Sarecka-Hujar, Aneta Ostróżka-Cieślik, Anna Banyś. Determinants of telemedicine development in health care system. Ann.Acad.Med.Siles. 2016; Vol.70, s.214-219

    15. Ilona Kopyta, Paweł Niemiec, Anna Balcerzyk, Ewa Emich-Widera, Ewa Pilarska, Karolina Pienczk-Recławowicz, Marek Kaciński, Janusz Wendorff, Tomasz Nowak, Tomasz Iwanicki, Beata Sarecka-Hujar, Iwona Żak. Fibrinogen alpha and beta gene polymorphisms in pediatric stroke - Case-control and family based study. Eur.J.Paediatr.Neurol.2015; Vol.19, No.2, p.176-180

    16. Ilona Kopyta, Mikołaj Zimny, Beata Sarecka-Hujar. The role of biochemical risk factors in the etiology of AIS in children and adults. Int.J.Neurosci.2015; Vol.125, No.12, p.875-884

    17. Anna Banyś, Beata Sarecka-Hujar, Andrzej Jankowski, Monika Zalewska. Impact of base type on diclofenac sodium release from semi-solid dosage forms. Ann.Acad.Med.Siles. 2014; Vol.68, No.1, s.1-8

    18. Ilona Kopyta, Beata Sarecka-Hujar, Joanna Sordyl, Ryszard Sordyl. The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review. Mol.Biol.Rep. 2014; Vol.41, No.7, p.4241-4251

    19. Beata Sarecka-Hujar, Iwona Żak, Ewa Emich-Widera et al. Association analysis of the E-selectin 98G>T polymorphism and the risk of childhood ischemic stroke. Cell Biochem. Funct. 2010; 28: 591-596.

    20. Ilona Kopyta, Beata Sarecka-Hujar, Ewa Emich-Widera et al. Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders. Wiad. Lek. 2010; 63:17-23.  

    21. Zak I, Sarecka-Hujar B, Kopyta I et al. The T allele of the 677C>T polymorphism of methylenetetrahydrofolate reductase gene is associated with an increased risk of ischemic stroke in Polish children. J Child Neurol. 2009; 24: 1262-1267. 

    22. Sarecka-Hujar B, Zak I, Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease. Clin Exp Med. 2009; 9: 117-124.


    More Info.
    Daniela Benedec
    Department of Pharmacognosy
    Iuliu Hatieganu University of Medicine and Pharmacy
    Romania
    dani_67ro@yahoo.com
    IJPSDR

    Research Interest: Natural Product Chemistry,Nanotechnology, Essential Oils, Nanobiotechnology, Antioxidants,Veterinary Medicine, Dermatology, Pharmacy, Medicinal and Pharmaceutical Chemistry, Thin Films and Nanotechnology, Medicinal Plants and Herbs, Plant Biotechnology, Antioxidant Activit, Polyphenols, Phenolic Compoun, DPP, Botan, Microbiology, Environmental Chemistry, Antioxidant Assays, Flavonoids, Biotechnology, Bioactivi, Phytochemicals,LC-MS, Medicinal Plants, Spectroscopy, Chromatography, Natural Products, Ethnomedicine, Natural Product Isolatio.

    More Info.
    Gilson Khang
    Chonbuk National University
    South Korea
    gskhang@jbnu.ac.kr
    IJPSDR

    Research Interest: Biotechnology, Artificial Intelligence, Neuroscience, Stem Cell Biology, Tissue Engineering, Stem Cell, Regenerative Medicine, Biodegradation.

    More Info.
    Hong-Tao Xiao
    Professor
    Department of Pharmacy Sichuan Provincial Peoples Hospital
    China
    xht927@163.com
    IJPSDR

    Research Interest: Experimental and clinical pharmacology about natural product, Pharmacokinetics of  medicinal plant.


    More Info.
    Yike Zou
    Department of Chemistry
    University of Pennsylvania
    USA
    zouyike@sas.upenn.edu
    IJPSDR

    Research Interest: Organic Chemistry: Total Synthesis of Complex Natural Product, Computational Chemistry: Conformational Analysis, Molecular Modelling and Spectra Simulation. Natural Product Discovery: Isolation, Structural Elucidation, and Absolute Configuration Deter-mination of Natural Product.

    More Info.
    Eleftherios Pelechas
    Epidemiology
    Grigore T. Popa University of Medicine and Pharmacy
    Romania
    pelehas@yahoo.com
    IJPSDR

    Research Interest: Epidemiology, Health Management and Rheumatology.

    More Info.
    Vijay Kumar Nekkanti
    Research Assistant Professor
    Western University of Health Sciences
    USA
    vnekkanti@westernu.edu
    IJPSDR

    Research Interest: Liposomes, Drug Nanoparticles, Solid Lipid Nanoparticles and Lipid Based Drug Delivery Systems.

    More Info.
    Lei Wang
    School of Pharmacy
    Queen s University Belfast
    UK
    l.wang@qub.ac.uk
    IJPSDR

    Research Interest: Natural drug discovery, Isolation, Physiological and pharmacological characterization of venom/toxin peptides and proteinswith animal tissues, Natural peptides and proteins analytical Chemistry, Mass spectrometry analysis, Molecular biology, Synthetic peptide analogues and their interaction with antibodies and receptors, Identification of novel drug targets, Biomarkers, Ion channel.

    More Info.
    Thierry Vandamme
    Professor
    University of Strasbourg
    Belgium
    vandamme@unistra.fr
    IJPSDR

    Research Interest: Medicine, Pharmacology, Pharmacy, Cell Culture,Genetic Engineering, Medicinal and Pharmaceutical Chemistry, Medical Neurosciences, Pharmaceutical Development.

    More Info.
    Wei-Gang Hu
    Bio-Threat Defence Section
    DRDC Suffield Research Centre
    Canada
    Wei-Gang.Hu@drdc-rddc.gc.ca
    IJPSDR

    Research Interest: Molecular Biology, Immunology (antibodies, vaccines), and Microbiology (viruses, bacteria, and toxins).

    More Info.
    Darshana Jani
    Global Research and Development
    USA
    Darshana.Jani@pfizer.com
    IJPSDR

    Research Interest: Immunogenicity, PK, Biomarker, Regulated and non regulated bioanalysis.

    More Info.
    Francesco Maione
    Department of Pharmacy
    University of Naples Federico II
    Italy
    francesco.maione@unina.it
    IJPSDR

    Research Interest: Inflammation, Immunopharmacology, Pharmacology of Natural Products/Compounds.

    More Info.
    Gitali Indra
    Asst. Professor
    Department of Pharmaceutical Sciences
    Oregon State University
    USA
    indrag@onid.orst.edu
    IJPSDR

    Research Interest: Elucidate the molecular and cellular mechanisms of contribution of hair follicle stem cells in wound repair and regeneration and identify new therapeutic targets toward the goal of accelerating wound healing and to identify natural compounds that are effective against head and neck cancer.

    More Info.
    Assem Mahmoud Eelsayed Barakat
    Assistant Professor
    Organic Chemistry
    King Saud University
    Saudi Arabia
    ambarakat@ksu.edu.sa
    IJPSDR

    Research Interest: Green Chemistry, Development of new catalytic asymmetric methodologies, Development of new green synthetic methodologies for desired target molecule, Development and synthesis of chiral reagents, metal catalysts in asymmetric synthesis to synthesize novel bioactive compounds, Design and synthesis of heterocycle derivatives as potential pharmaceuticals in medicine, X-Ray diffraction for elucidation the chemical structures of organic compounds.

    More Info.
    Mafalda Ascensao Videira
    Assistant Professor
    Department of Pharmaceutics
    University of Lisbon
    Portugal
    mvideira@ff.ul.pt
    IJPSDR

    Research Interest: Cancer Diagnostics, Cancer Research, Clinical Trials, Ophthalmology, Business, Economic Genetics, Stem Cell Biology, Cell Biology, Translational Cancer Research, Business Ethics, Oncology, Molecular Biology.

    More Info.
    View more
    mendeley

    Oropharyngeal Pathogenic Bacteria: Carriage, Antimicrobial Susceptibility Pattern and Associated Risk Factors among Febrile Patients

    DOI Logo 10.17352/ijpsdr.000037

    Published On: March 08, 2022 | Pages: 006 - 012

    Author(s): Merete Tesfaye Wondimu, Teklu Shiferaw Simbo, Tolossa Eticha Chaka, Haile Abera Lemi*, Biruk Yeshitila, Mekonnen Teferi, Kemal Jemal and Worku Bedada*
    Abstract View Full Article View
    mendeley

    Glass Delamination in sterile formulations and Drug Recalls: A Review

    DOI Logo 10.17352/ijpsdr.000036

    Published On: January 19, 2022 | Pages: 001 - 005

    Author(s): Kabirdas B Ghorpade* and Sharda M Shinde
    Abstract View Full Article View
    mendeley

    Analysis of the mechanism underlying the effects of cyclophosphamide against triple-negative breast cancer by an integrative bioinformatics approach

    DOI Logo 10.17352/ijpsdr.000035

    Published On: December 24, 2021 | Pages: 006 - 015

    Author(s): Maojing Wang, Wenwen Li, Ding Li and Zhiwu Han*
    Abstract View Full Article View    
    mendeley

    The use of pentoxifylline in male reproduction abnormalities

    DOI Logo 10.17352/ijpsdr.000034

    Published On: August 10, 2021 | Pages: 003 - 005

    Author(s): Aamir Jalal Al-Mosawi*
    Abstract View Full Article View    
    mendeley

    Is it possible to perform molecular hybridization between acetaminophen and nitric oxide donor molecule?

    DOI Logo 10.17352/ijpsdr.000033

    Published On: March 09, 2021 | Pages: 001 - 002

    Author(s): João Gabriel Gouvêa-Silva, Leonardo Ribeiro Bernardo, Ygor Jessé Ramos* and Antônio José Calixto de Souza
    Abstract View Full Article View    
    mendeley

    A cross sectional study of alcohol consumption and risk factors

    DOI Logo 10.17352/ijpsdr.000032

    Published On: September 23, 2020 | Pages: 034 - 037

    Author(s): R Dinesh Kumar, J Kalaiselvi and Siva S*
    Abstract View Full Article View    
    mendeley

    Developing analytical parameters and evaluation of thermo fisher urinary creatinine enzymatic method to implement in open system chemistry analyzers

    DOI Logo 10.17352/ijpsdr.000031

    Published On: September 16, 2020 | Pages: 030 - 033

    Author(s): Ashraf Mina*, Leah McNeice, Shanmugam Banukumar and Santiago Vazquez
    Abstract View Full Article View    
    mendeley

    Development and optimization of mucoadhesive microballons of nizatidine for management of peptic ulcer

    DOI Logo 10.17352/ijpsdr.000030

    Published On: June 29, 2020 | Pages: 021 - 029

    Author(s): Seema Jain, Neha Jain, Mohan Lal Kor, Umesh Kumar Jain and Abhishek Kumar Jain*
    Abstract View Full Article View    
    mendeley

    An overview on NMR spectroscopy based metabolomics

    DOI Logo 10.17352/ijpsdr.000029

    Published On: June 03, 2020 | Pages: 016 - 020

    Author(s): Nalini Kanta Sahoo*, G Tejaswini, Madhusmita Sahu and KS Muralikrishna
    Abstract View Full Article View    
    mendeley

    Bacteriocin-like protein produced Brevibacillus laterosporus that can inhibit the growth of drug resistant bacteria

    DOI Logo 10.17352/ijpsdr.000028

    Published On: June 03, 2020 | Pages: 012 - 015

    Author(s): Monthon Lertcanawanichakul* and Kittisak Chawawisit
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJPSDR

    Google Reviews 11